tiprankstipranks
Impact BioMedical, Inc. (IBO)
:IBO
US Market

Impact BioMedical, Inc. (IBO) Financial Statements

105 Followers

Impact BioMedical, Inc. Financial Overview

Impact BioMedical, Inc.'s market cap is currently $63.08M. The company's EPS TTM is $-1.2711; its P/E ratio is -4.90; Impact BioMedical, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 32.00K$ 1.62M$ 0.00$ 0.00$ 0.00
Gross Profit$ -392.00K$ 1.62M$ 0.00$ -1.11M$ -1.11M
Operating Income$ -4.27M$ 383.35K$ -4.03M$ -3.45M$ -3.19M
EBITDA$ -12.51M-$ -2.84M$ -2.34M$ -2.07M
Net Income$ -11.84M$ -1.43M$ -4.34M$ -7.05M$ -1.30M
Balance Sheet
Cash & Short-Term Investments$ 3.00K$ 2.00M$ 1.00K$ 2.00K$ 46.00K
Total Assets$ 17.41M$ 20.29M$ 44.63M$ 46.50M$ 56.42M
Total Debt$ 0.00$ 8.88M$ 12.07M$ 9.99M$ 12.52M
Net Debt$ -3.00K$ 6.88M$ 12.07M$ 9.99M$ 12.48M
Total Liabilities$ 1.85M$ 13.05M$ 16.37M$ 13.83M$ 16.50M
Stockholders' Equity$ 12.61M$ 4.26M$ 25.22M$ 29.56M$ 36.61M
Cash Flow
Free Cash Flow$ -1.89M$ -5.64M$ -2.87M$ -2.52M$ -2.52M
Operating Cash Flow$ -1.89M$ -5.64M$ -2.85M$ -2.24M$ -2.24M
Investing Cash Flow$ 3.00K$ 2.88K$ -15.00K$ -349.00K$ -349.00K
Financing Cash Flow$ -109.00K$ 8.51M$ 2.87M$ 2.55M$ 2.55M
Currency in USD

Impact BioMedical, Inc. Earnings and Revenue History

Impact BioMedical, Inc. Debt to Assets

Impact BioMedical, Inc. Cash Flow

Impact BioMedical, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.